Evolving therapies, neurocognitive outcomes, and functional independence in adult survivors of childhood glioma

Author:

Papini Chiara1ORCID,Mirzaei S. Sedigheh2,Xing Mengqi2,Tonning Olsson Ingrid34,de Blank Peter M K56,Lange Katharine R7,Salloum Ralph8,Srivastava Deokumar2,Leisenring Wendy M9,Howell Rebecca M10,Oeffinger Kevin C11,Robison Leslie L12,Armstrong Gregory T12,Krull Kevin R1ORCID,Brinkman Tara M112ORCID

Affiliation:

1. Department of Psychology and Biobehavioral Sciences, St. Jude Children’s Research Hospital , Memphis, TN, USA

2. Department of Biostatistics, St. Jude Children’s Research Hospital , Memphis, TN, USA

3. Department of Pediatrics, Skåne University Hospital , Lund, Sweden

4. Department of Clinical Sciences, Pediatrics, Lund University , Lund, Sweden

5. Department of Pediatrics, Cincinnati Children’s Hospital Medical Center , Cincinnati, OH, USA

6. , The Cure Starts Now Brain Tumor Center Cincinnati Children’s Hospital Medical Center , Cincinnati, OH, USA

7. Divison of Pediatric Oncology, Hackensack Meridian Children’s Health , Hackensack, NJ, USA

8. Pediatric Brain Tumor Program, Division of Hematology, Oncology & Bone Marrow Transplant, Nationwide Children’s Hospital , Columbus, OH, USA

9. Clinical Research Division, Fred Hutchinson Cancer Research Center , Seattle, WA, USA

10. Division of Radiation Oncology, Department of Radiation Physics, The University of Texas at MD Anderson Cancer Center , Houston, TX, USA

11. Department of Medicine, Duke University , Durham, NC, USA

12. Department of Epidemiology and Cancer Control, St. Jude Children’s Research Hospital , Memphis, TN, USA

Abstract

Abstract Background Treatment of childhood glioma has evolved to reduce radiotherapy exposure with the goal of limiting late toxicity. However, the associations between treatment changes and neurocognition, and the contribution of neurocognition and chronic health conditions to attainment of adult independence, remain unknown. Methods Adult survivors of childhood glioma diagnosed in 1970-1999 in the Childhood Cancer Survivor Study (n = 1284; median [minimum-maximum] 30 [18-51] years of age at assessment; 22 [15-34] years from diagnosis) self-reported neurocognitive impairment and chronic health conditions. Multivariable models evaluated associations between changes in treatment exposures (surgery only, chemotherapy [with or without surgery], cranial radiation [with or without chemotherapy and/or surgery]), and neurocognitive impairment. Latent class analysis with 5 indicators (employment, independent living, assistance with routine and/or personal care needs, driver’s license, marital or partner status) identified classes of functional independence. Path analysis tested associations among treatment exposures, neurocognitive impairment, chronic health conditions, and functional independence. Statistical tests were 2-sided. Results Cranial radiation exposure decreased over time (51%, 1970s; 46%, 1980s; 27%, 1990s]. However, compared with siblings, survivors with any treatment exposure were at elevated risk for neurocognitive impairment, including surgery only (eg, memory: relative risk = 2.22; task efficiency: relative risk = 1.88; both P < .001). Three classes of functional independence were identified: independent (58%), moderately independent (20%), and nonindependent (22%). Cranial radiation was associated with nonindependence through impaired task efficiency (β = 0.06), sensorimotor (β = 0.06), and endocrine (β = 0.10) chronic health conditions and through the associations between these conditions and task efficiency (each β = 0.04). Sensorimotor and endocrine chronic health conditions were associated with nonindependence through memory. Conclusion Most long-term glioma survivors achieve adult independence. However, functional nonindependence is associated with treatment-related neurocognitive impairment and chronic health conditions.

Funder

National Cancer Institute

Cancer Center Support

American Lebanese-Syrian Associated Charities

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3